[HTML][HTML] Immune checkpoint inhibitors in hepatocellular carcinoma: an overview

DJ van Doorn, RB Takkenberg, HJ Klümpen - Pharmaceuticals, 2020 - mdpi.com
Patients with hepatocellular carcinoma (HCC) face a common type of cancer, which is
amongst the most deadly types of cancer worldwide. The therapeutic options range from …

CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma

J Luo, J Wang, J Huang - Bioscience Reports, 2021 - portlandpress.com
Cyclin dependent kinase inhibitor 2A (CDKN2A) is an essential regulator of immune cell
functionality, but the mechanisms whereby it drives immune infiltration in hepatocellular …

[HTML][HTML] Expression of m6A regulators correlated with immune microenvironment predicts therapeutic efficacy and prognosis in gliomas

S Xu, L Tang, G Dai, C Luo, Z Liu - Frontiers in cell and …, 2020 - frontiersin.org
Background N6-methyladenosine (m6A) RNA methylation and tumor immune
microenvironment played crucial roles in cancer development. However, their association in …

[HTML][HTML] Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: a systematic review and critical …

L Li, X Li, W Li, X Ding, Y Zhang, J Chen, W Li - BMC cancer, 2022 - Springer
Objective To describe and analyze the predictive models of the prognosis of patients with
hepatocellular carcinoma (HCC) undergoing systemic treatment. Design Systematic review …

[HTML][HTML] Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment …

C Guo, Y Tang, Z Yang, G Li, Y Zhang - Frontiers in Immunology, 2022 - frontiersin.org
Hepatocellular carcinoma (HCC), accounting for~ 90% of all primary liver cancer, is a
prevalent malignancy worldwide. The intratumor heterogeneity of its causative etiology …

[HTML][HTML] Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer

J Mei, Y Xing, J Lv, D Gu, J Pan, Y Zhang… - International …, 2020 - Elsevier
Cervical cancer (CeCa) is becoming an intractable public health issue worldwide. Emerging
evidence uncovers that the tumor progression and prognosis of patients with CeCa are …

[HTML][HTML] Establishment and analysis of a disease risk prediction model for the systemic lupus erythematosus with random forest

H Chen, L Huang, X Jiang, Y Wang, Y Bian… - Frontiers in …, 2022 - frontiersin.org
Systemic lupus erythematosus (SLE) is a latent, insidious autoimmune disease, and with the
development of gene sequencing in recent years, our study aims to develop a gene-based …

[HTML][HTML] A novel RNA binding protein-related prognostic signature for hepatocellular carcinoma

Y Huang, S Chen, W Qin, Y Wang, L Li, Q Li… - Frontiers in …, 2020 - frontiersin.org
Hepatocellular carcinoma (HCC) is a highly malignant and aggressive cancer with high
recurrence rates and mortality. Some studies have illustrated that RNA binding proteins …

[HTML][HTML] Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment

J Liu, S Nie, Z Wu, Y Jiang, Y Wan, S Li, H Meng… - Genomics, 2020 - Elsevier
In this study, we devoted to investigate immune-related genes and tumor microenvironment
(TME) in EC based on The Cancer Genome Atlas (TCGA) database. In total 799 up …

[HTML][HTML] Identification of mitochondrial-related prognostic biomarkers associated with primary bile acid biosynthesis and tumor microenvironment of hepatocellular …

T Zhang, Y Nie, J Gu, K Cai, X Chen, H Li… - Frontiers in …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is one of the leading causes of tumor-associated deaths
worldwide. Despite great progress in early diagnosis and multidisciplinary tumor …